Tuesday - August 25, 2026
Goodwin Advises AbCellera Biologics on $200 Million Public Offering
August 24, 2026
BOSTON, Massachusetts, Aug. 24 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Advises AbCellera Biologics on $200 Million Public Offering

*

The Life Sciences team advised AbCellera Biologics ("AbCellera") on completing an oversubscribed underwritten public offering of 17,435,897 common shares at a public offering price of $9.75 per share and, in lieu of common shares to certain invest . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products